OOIR: Observatory of International Research

Papers

(The TQCC of Journal of the Peripheral Nervous System is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Abstracts	323
	60
	33
	33
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”	27
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	24
PNS Abstracts 2023	19
Antecedent infections in Guillain‐Barré syndrome in endemic areas of arbovirus transmission: A multinational case‐control study	19
Toxic medications in Charcot–Marie–Tooth patients: A systematic review	18
Nerve ultrasound as a screening tool for inherited sensory neuronopathy	17
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice	16
Ofatumumab for treating autoimmune nodopathy	16
	16
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort	15
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)	14
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study	13
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders	13
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy	12
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy	12
Issue Information	12
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)	12
Issue Information	11
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials	11
Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT	11
Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology	11

Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy	10
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China	10
A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state‐of‐the‐art tracking methods	9
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision	9
Sensory neuronopathies: A case series and literature review	9
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study	9
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version	9
IgM anti‐MAG^± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei	9
Nerve biopsy in acquired neuropathies	8
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia	8
Techniques for the standard histological and ultrastructural assessment of nerve biopsies	8
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis	8
Issue Information	8
Issue Information	7
Issue Information	7
Issue Information	7
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A	7
	7
	7
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency	7
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy	7
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)	7
Issue Information	6
	6
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers	6
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes	6
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy	6
ABSTRACT	6
The autoimmune vulnerability of the node of Ranvier	5
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”	5
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies	5
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po	5
	5
Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first‐line therapy	5
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience	4
	4
Issue Information	4
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era	4
VitaminB6levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy	4
Acquired Transthyretin Amyloidosis in Domino Liver Transplantation Treated With Gene‐Silencers	4
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?	4
Anxiety and depression in small fiber neuropathy	4
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease	4
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy	4
2021 Peripheral Nerve Society virtual event	4
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis	4
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial	3
Genetic and Clinical Features of 10 Families With Hereditary Sensory Neuropathies	3
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease	3
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis	3

	3
Phenotypic features of RETREG1‐related hereditary sensory autonomic neuropathy	3
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study	3
Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort	3
Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation	3
Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies	3
Issue Information	3
Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling	3
Issue Information	3
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor	3
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review	3
The NCX1 calcium exchanger is implicated in delayed axotomy after peripheral nerve stretch injury	3
Earlier diagnosis of peripheral neuropathy in primary care: A call to action	3